In addition, another aggressive subtype of breast cancer, HER2-positive breast cancer, has also been reported to have a relatively higher tumor mutation burden and Tumor-infiltrating lymphocytes (TILs) than the luminal subtype (Holgado et al., 2018). Here, ERBB2 is linked to neoplasm.